Adult Hepatic Progenitor Cells by Vestentoft, Peter Siig
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Adult Hepatic Progenitor Cells
Peter Siig  Vestentoft
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/58814
1. Introduction
The liver is the largest internal organ of the body only second in size compared to the skin.
The liver not only functions as an endocrine and exocrine organ, but it also performs a
multitude of vital functions including glycogen storage, detoxification and plasma protein
synthesis [1–4]. The liver receives nutrients and environmental toxins from the digestive tract
through the portal vein. This direct transport of potentially harmful agents is hypothesized to
have exerted an evolutionary pressure on the liver to possess multiple pathways for regener‐
ation [4,5]. In fact, the regenerative capacity of the liver is so enormous that this was renowned
in ancient times and described in Mediterranean folklore. According to Greek mythology the
Titan Prometheus stole fire from the Gods of Olympia and gave it to the mortals. As a
consequence, Zeus, the king of Gods, chained Prometheus to a rock. An eagle would then
appear each day and pecked out part of Prometheus’ liver only to let it regenerate overnight
[1]. This punishment was to be repeated for eternity, but according to one version of the story,
Heracles (Hercules) eventually killed the eagle and freed Prometheus.
Despite of the famed renewal capacity of the liver, hepatic diseases constitute a worldwide
problem. Hepatic diseases can broadly be divided into two major groups: acute and chronic
liver diseases. Acute liver failure is characterized by the manifestation of sudden severe hepatic
injury that can have several etiologies [6,7]. Frequent causes included viral hepatitis or drug
intoxication, commonly paracetamol, leading to hepatic encephalopathy, coagulopathy and
often progressive multiorgan failure [6,8–11]. In developed countries, acute liver failure is
relatively rare with an incidence estimated between 1-6 cases per million people each year [6,
12]. In contrast, chronic liver diseases are caused by prolonged insults. Common causes include
sustained alcohol consumption, non-alcoholic fatty liver disease and hepatitis B or C virus
infection [2]. These insults can lead to hepatic fibrosis, a form of wound healing characterized
by the presence of collagen-rich septae connecting the so-called portal areas. If untreated, this
potentially reversible manifestation, can progress to end stage cirrhosis, where hepatic
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architecture is greatly disturbed and scar tissue encircles nodules of remaining hepatocytes
[7,13–17]. Chronic liver diseases are estimated to affect 170 million patients worldwide. Those
cases eventually progress to fibrosis and possibly cirrhosis in 25-30 % of these patients [2].
Where acute hepatic failure involves sudden massive cell death, chronic liver diseases are
conversely characterized by continuous cell death [18–20].
When hepatic regeneration is hindered orthotopic liver transplantation is the only treatment
that radically improves the outcome of hepatic failure [2,21]. However, the worldwide shortage
of liver donors result in death of many patients waiting for transplantation [22]. Research into
alternative methods of therapeutic treatment is therefore highly needed. The possibility of
culturing hepatic stem cells holds the promise to treat certain liver diseases, even with
autologous stem cells. This include correcting metabolic diseases characterized by inherited
defects of hepatic enzymes or treating fulminant hepatic failure characterized by rapid onset
of liver failure and death, when donor organs are unavailable [23]. The use of autologous stem
cells would additionally prevent the lifespan administration of immunosuppressive agents
currently employed to prevent allograft rejection. Therefore, there has been an increasing
interest into using hepatic stem cell-based therapies as novel alternatives to traditional liver
treatments. However, the stem cell biology of the liver is not well understood. In particular,
the lack of specific markers for hepatic stem cell identification has hindered their characteri‐
zation and isolation [24–28].
The present chapter will provide an overview of current knowledge of the rodent and human
hepatic stem cell niche.
In particular, the chapter will go through the development of the hepatic stem cell niche, the
associated extracellular matrix molecules and support cells. Attention will also be given to the
various modes of hepatic regeneration and the involvement of hepatic stem cells in cancerous
disease states.
2. Stem cells
Even though stem cells have been identified and characterized in several organs, no universally
accepted definition of what constitutes a stem cell has been defined [29]. However, a broadly
accepted view is that stem cells are cells that hold a capacity for unlimited or prolonged self-
renewal and can also give rise to at least one type of highly differentiated progeny [30].
However, many classes of stem cell exist with different potentials. These range from the
totipotent fertilized egg from which entire organisms develop over pluripotent embryonic
stem cells that can give rise to the three germ layers to the unipotent tissue stem cells.
Typically, tissue or intra-organ stem cells are less differentiated cells that exist in a mitotically
quiescent form [31]. This class of stem cells are so-called “determined”, meaning that they lack
markers of final differentiation, but are able to divide and differentiate into highly specialized
effector cells [32,33]. When needed tissue stem cells are activated to divide and clonally
regenerate the tissue in which they are located [32,34]. Upon activation, tissue stem cells would
Adult Stem Cell Niches174
perform either symmetric or asymmetric cell division [30]. Symmetric stem cell division give
rise to two daughter cells that themselves are stem cells, thereby maintaining the stem cell
pool. Alternatively, this form for division may result in two daughter cells committed for
differentiation. Asymmetric stem cell division, on the other hand, produces one stem cell and
one differentiated daughter cell. Differentiated daughter cells are also known as progenitor
cells or transit amplifying cells. They divide rapidly in order to generate a pool of continually
more differentiated cells en route to replace senescent or damaged tissue cells [34]. Early
progenitor cells hold multi-lineage potential and have characteristics similar to the parent stem
cell whereas late progenitor cells are more differentiated and produce single-lineage progeny
[32]. Therefore, even though stem cells have a high self-renewal capacity, they may divide
relatively infrequently, whereas the transit amplifying cells greatly increase in number and
differentiate into given tissue cells.
3. Stem cell niche
The potency of stem cells requires tight regulation of their behavior. Stem cell quiescence and
activation must be regulated according to the needs of the organism. A critical actor in
mediating the balanced response of stem cells to the needs of the organism is the stem cell
niche.
The stem cell niche concept was first proposed by Schofield who conducted bone marrow
studies [35]. It was suggested that stem cells reside in compartments that promote and maintain
their characteristics [35]. It is believed that once postnatal tissues are formed, intra-organ stem
cells reside in these special tissue microenvironments or niches. However, upon activation, the
niche must change the composition of its microenvironment from favoring stem cell quiescence
to induce stem cell activation and proliferation. Studies on Drosophila spp. gonads have helped
understanding the factors constituting the stem cell niche and greatly expanded knowledge
of stem cell activation and the generation of transit amplifying cells [36]. These studies have
revealed a basal theme to reoccur. Structurally, the typical stem cell niche consists of stem cells
resting on a scaffold of extracellular matrix components, having cell-cell interactions with
differentiated neighboring cells [36–38]. In Drosophila spp. gonads, the extracellular matrix
forms a repressing environment to stem cell differentiation, while promoting cellular adhesion
[36]. Immediately outside this repressive zone, stem cell adherence is reduced while cellular
differentiation is stimulated [36]. More specifically, integrins have been identified as key
elements in this adhesion process. These transmembrane proteins that mediate adhesion to
the extracellular matrix, are often highly expressed in stem cells and can suppress terminal
differentiation in epidermal stem cells, for instance [39,40]. Conversely, the loss of integrins is
associated with the epidermal stem cell niche disappearance, characterized by cellular
differentiation [30].
The key factor to identify stem cell niches is the stem cell localization itself. For this pur‐
pose,label-retention assays may be applied, two common labels being 3H-thymidine and the
thymidine analog BrdU. Upon asymmetric cellular division, stem cells may incorporate either
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of these labels into their DNA thereby retaining 50% of the label with the resulting daughter
stem cell and 50% with the transit amplifying cell. As transit amplifying cells are fast cycling
the label is gradually diluted in the following chase period while the slow cycling daughter
stem cell retain the marker. Use of these and similar label-retaining assays have been employed
to identify the stem cell niche of the skin, hair follicle and peripheral cornea [41–45]. Though
being an intriguing method for locating stem cells, label-retention techniques has certain
disadvantages. Stem cells that did not enter the cell cycle during the labelling period will for
instance remain unmarked, while progenitor cells that terminally differentiate and stop cell
division can retain markers for longer periods of time [46]. Stem cells and their niches have,
never the less, been identified in several organs. In vertebrates these include the bulge region
of the hair follicle, the bone marrow and the lover region of the crypts in the small intestine
[41,47–49]. The common denominator of these organs, however, is that they are characterized
by a continuous supply of cells descending from the stem cells. Stem cells in tissues charac‐
terized by a lower cellular turnover are, on the contrary, more difficult to identify. One such
organ is the liver, where mitotically quiescent hepatocytes have relatively long life spans and
high proliferative capacities [50,51].
4. Hepatic anatomy
Although many cell types are present, the liver is characterized by two epithelial tissue
components; cholangiocytes and hepatic cords containing hepatocytes, respectively. The
hepatocytes secrete serum proteins, including albumin, and express monooxygenases from
the cytochrome P450 family, the major enzymes involved in oxidative metabolism of xenobi‐
otics [52]. Cholangiocytes, on the other hand, form biliary channels transporting bile from the
liver towards the bile bladder.
Examination of hepatic tissue sections reveal an unvarying landscape of cords of hepatocytes
with scattered central veins and so-called portal triads or portal tracts. The latter contain bile
ducts and branches from the portal vein and portal artery, thereby forming a triad [53].
However, from a three-dimensional perspective, this dull landscape masks a highly complex
organ [53,54]. Accurately defining the livers functional entities have historically been difficult,
as multiple functions could be applied based on either enzymatic expression patterns or
histological observations. A frequently used definition is the simple histological unit “lobule”
(figure 1). The classic lobule is envisioned as a two-dimensional hexagonal structure centered
around a central vein [55]. Each hexagonal corner contain a portal tract and cords of hepato‐
cytes extend from the hepatocytic limiting plate at the periportal space, towards the central
vein [55]. The terminal segments of the biliary system in the portal tracts connect directly with
the hepatic cords through a specialized structure known as the Canal of Hering – thought to
constitute the hepatic progenitor cell niche [56]. Canals of Hering are formed partly by biliary
cells and partly by hepatocytes near the limiting plate [56]. Hepatic cords are separated from
each other by a special form of blood vessels called sinusoids [55]. The sinusoids are lined by
endothelial cells with open pores, or fenestrae, lacking a diaphragm and a basal lamina [57].
The resulting high endothelial permeability facilitate the exchange of macromolecules, solutes
Adult Stem Cell Niches176
and water between sinusoidal blood and hepatocytes [57]. The sinusoidal wall is additionally
separated from the hepatocytes by a lumen termed the space of Disse. The predominant view
is that blood drain from the portal vein and portal artery branches and blends in the sinusoids
from where it drains into the central vein [54,55]. Lymph, on the other hand, is thought to be
generated by filtration of sinusoidal blood into the space of Disse from where it flows towards
lymphatic vessels located in the portal tracts [54]. Bile canaliculi are narrow spaces formed
from the apical membranes of adjacent hepatocytes in the hepatic cords [54]. Bile originating
from the bile canaliculi is transported towards terminal bile ducts in the portal tracts through
the canal of Hering [54,56].
Non-parenchymal cell types also present in the liver include stellate cells and Kupffer cells.
Hepatic stellate cells, also known as Ito cells, are starshaped and contain lipid droplets with
vast amounts of vitamin A [58]. In normal liver they are located to the space of Disse which is
suggested to constitute the hepatic stellate cell niche [59]. Kupffer cells, on the other hand, are
hepatic macrophages involved in the phagocytosis of cellular debris, extracellular matrix
components and release of inflammatory factors [60].
5. Liver development
The liver in an endodermal derived organ with hepatocytes and cholangiocytes originating
from a common progenitor termed “hepatoblast” or “primitive hepatocyte” [61]. Development
of the liver goes through sequential stages including induction, specification, proliferation and
maturation steps. The endoderm is important for inducing development of the neighboring
cardiogenic mesoderm followed by maturation of the heart. Embryonic development of the
liver is initiated in the ventral part of the anterior endoderm, whereas pancreas coordinately
Figure 1. A. Cartoon of a stylized hepatic lobule. Each hexagonal corner of the hepatic lobule is marked by a portal
area containing a portal vein, a portal artery and a bile duct. A central vein mark the center of the lobule. B. Hematoxy‐
lin and eosin staining of a tissue section from adult normal human liver. A portal area containing a portal vein, portal
artery and bile duct is discernible. Magnification x100.
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develops from the dorsal part. Within a short period of time, in a so-called “window of
opportunity” around embryonic day (E) 8.5-11.5 in mouse endoderm, the anterior endoderm
is competent for activation of a hepatic development gene program [62]. At the time of hepatic
induction, the adjacent mesenchymal tissue, comprising the cardiogenic mesoderm and
septum transversum, produces subtypes of growth factors: fibroblast growth factor (FGF) and
bone morphogenetic protein (BMP), respectively [63]. Growth factors acid FGF, basic FGF,
FGF4, BMP 2, and BMP4 initiate a hepatic gene expression program, while FGF or cardiogenic
mesoderm suppresses the pancreatic gene expression program [62]. In the absence of BMPs
or FGFs, the pancreatic gene expression program is initiated while the hepatic gene program
is suppressed [62].
Following induction of hepatic gene expression, the endodermal cells adopt a columnar
appearance at E8.5 and express albumin. At E9.5 a thickening of the endoderm is observed,
interceded by primitive endothelial cells from the septum transversum [62,64]. This prospec‐
tive liver, termed the hepatic diverticulum or “liver bud”, is visible in the human embryo at
the 17 somite stage, corresponding to 3 weeks and 5 days post conception [53,64]. Signaling
molecules, including BMPs, hepatocyte growth factor (Hgf) and vascular endothelial growth
factor receptor 2 (Vegfr-2) from the septum transversum and endothelial cells induce prolif‐
eration and migration of hepatoblast positive for cytokeratin (CK19), Hepatocyte Paraffin 1
(HepPar1), α-fetoprotein (AFP) and albumin, into the adjacent septum transversum [62,65–
69]. At E11 the hepatoblasts addionationally stain for the intermediate filament proteins CK8,
CK14 and CK18 [70–72]. Concurrent with the hepatoblast invasion the endothelial cells
coalesce around spaces in the septum transversum thereby forming anastomosing primitive
blood vessels around which hepatoblast are situated. The endodermal invasion displaces the
septum transversum that eventually form the liver capsule, mesenchyme and possibly the
hepatic stellate cells [62,68,69,73,74].
At E14 (in mouse) hematopoietic cells colonize the liver, making it a prenatal site for hemato‐
poiesis. Concomitantly, hepatoblasts express markers of both the hepatocytic and cholangio‐
cytic lineages and are capable of differentiating into either of the two epithelial cell types. The
hepatoblasts, however, gradually commit to either the hepatocytic or cholangiocytic lineages.
Three transcriptions factors, Hepatocyte Nuclear Factor (HNF)-4α, HNF-6 and HNF-1β, are
found to be particularly important in this process. Microarray data have demonstrated that
HNF-4α bind approximately half of the active genes in liver and is essential for determination
toward a hepatocytic fate [75,76]. On the other hand, HNF-6 and HNF-1β are essential for
development of the biliary lineage. Knockout mice for HNF6 and its downstream target
HNF1β, develop no gallbladder and display abnormal development of the intrahepatic and
extrahepatic bile ducts [77,78]. Around E16 (mouse) the hepatoblast are commited to either
the hepatocytic or cholangiocytic lineages and are thereby no longer bipotential [62,79,80].
During development of the liver, morphogenesis of the biliary tree is also said to proceed
through a series of developmental stages. These are categorized as the ductal plate, remodeling
bile duct and remodeled bile duct stages [79]. The earliest indicator of biliary development
comes from studies of the transcription factor SRY-related HMG box transcription factor 9
(SOX9). SOX9 is essential for the formation of certain stem cell niches, such as the hair follicle
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stem cell compartment [81]. SOX9 is expressed in the hepatic diverticulum but disappears
during the endodermal invasion of the septum transversum. At E11.5, however, SOX9 is
reexpressed in hepatoblasts located near the developing portal veins [82]. These prospective
cholangiocytes lining the mesenchyme surrounding developing portal veins form a single-
layered ring at E14.5 termed the “ductal plate”. Studies on cells isolated from the ductal plate
and from adult livers have shed important information on this structure. Cells from adult livers
and the ductal plate, positive for epithelial cell adhesion molecule (EpCAM) and CK19 and
negative for AFP can give rise to both the hepatic and biliary lineages, when injected into
immunodeficient NOD/SCID mice [83,84]. The ductal plate is therefore not only suggested to
constitute the pre-and perinatal hepatic progenitor cell niche, but also to be directly antecedent
to the canal of Hering, the presumed adult hepatic progenitor cell niche [83–85].
The ductal plate, which can be envisioned as a biliary sleeve, increase expression of CK8, 18
and 19 relative to the remaining parenchymal cells [86,87]. Through a unique mode of
tubulogenesis the cholangiocytes induce neighboring hepatoblast to differentiate into cholan‐
giocytes themselves thereby developing a two-layered transiently asymmetric ductal plate
around E16.5 [79,82]. Focal lumina appear between the mesenchymal and parenchymal ductal
plate facing layers, thereby giving rise to early bile ducts at E16.5 [79]. In the following
remodeling phase, these primitive bile ducts migrate into the portal mesenchyme in a complex
process timely coordinated with the formation of hepatic portal arteries [65]. The parts of the
ductal plate, which are not involved in bile duct formation, possibly regress as a result of
apoptosis [88]. As of a result, the intrahepatic bile ducts loose contact with the ductal plate and
become fully embedded in the portal mesenchyme in the remodeled stage. However, the
intrahepatic bile duct system is still immature until several weeks after birth and remnants of
the ductal plate can be identified, in particular, at the smaller vein branches [86,89]. As a final
step in the maturation process, developing cholangiocytes initiate expression of CK7, a marker
of adult bile duct cells [53,86]. The outlined development of the intrahepatic bile duct system
is initiated at the hepatic hilum from where it gradually progresses towards the periphery of
the liver, where the smaller portal branches reside [89].
6. Hepatic tissue homeostasis
The wide range of important metabolic functions performed by the liver and its proximity to
ingested environmental toxins are hypothesized to have imparted the livers tremendous
capacity for adaptation and regeneration [3,90].
Hepatocytes are the main component of liver and therefore, the most vulnerable to damage.
The generation of adult hepatocytes, under non-pathogenic conditions, has been widely
disputed. In normal liver, parenchymal turnover is slow with hepatocyte lifespans estimated
150 to 450 days in rat [50,51,91,92]. With a turnover rate of normal liver cells of approximately
1 in 20,000-40,000 at any given time the entire liver is estimated to be replaced by normal tissue
at least once a year [93]. As hepatocytes supposedly are terminally differentiated cells, they
were once hypothesized only to possess the capacity for one or two cell divisions. A number
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of studies of label-retaining markers of cells based on the incorporation of markers such as
tritiated thymidine into DNA in rats or lack of markers such as cytochrome c in humans have
located proliferative hepatocytes in the periportal region [94,95]. Cell tracking has illustrated
a gradual invasion of these recognizable cells from the portal tract towards the terminal central
vein. Based on these and similar experiments the “streaming liver” hypothesis was suggested
in which mitotically active hepatocytes at the limiting plate in the periportal region continu‐
ously provided hepatocytic offspring. In a unidirectional fashion, these hepatocytes are
hypothesized to stream along the sinusoids as they gradually change enzymatic expression
and eventually replace dead hepatocytes in the perivenous region [94]. However, this model
is still quite controversal. Long-term labelling of hepatocytes with beta-galactosidase, an
enzyme capable of converting X-gal into an insoluble blue compound, found positive clusters
of hepatocytes, ergo cells that had divided, throughout the liver lobule thereby contradicting
the streaming liver hypothesis [51].
The relative mitotic quiescence of hepatocytes and cholangiocytes mask their huge prolifera‐
tive potential. Resecting two-thirds of the liver in accordance with the partial hepatectomy
protocol (PHx) leads to complete regrowth in approximately 10 days [1,3]. This regrowth is,
however, not a true regeneration, given that it does not recreate original hepatic morphology
but is compensatory hyperplasia in the residual liver lobes [55]. Even with this relatively harsh
treatment of the liver, only 1-2 proliferative events of hepatic epithelial cells are needed to lead
to complete compensatory regrowth with no or very little hepatic stem cell contribution [1,96].
Impressively, this procedure can be repeated at least 12 times in rats without regenerative
failure or endangering liver function as hepatocytes maintain a fully differentiated state [97].
In an experimental animal model, mice deficient for the tyrosine catabolic enzyme, fumaryla‐
cetoacetate hydrolase (FAH), suffer from hepatocyte damage due to accumulation of fumar‐
ylacetoacetate and its precursor maleylacetoacetate [98]. However, wild-type hepatocytes are
capable of rescuing this phenotype. In an elegant study serial transplantations of wild-type
hepatocytes into FAH deficient mice repopulated 6 generations of livers corresponding to 69
cell doublings [98]. Therefore, during normal tissue homeostasis, hepatocytes could be
regarded as the functional unipotent hepatic stem cell, capable of giving rise to more than 50
livers [1]. Furthermore, in some chronic biliary diseases such as primary biliary cirrhosis and
primary sclerosing cholangitis, hepatocytes have even been observed differentiating into
biliary cells [99,100]. Nonetheless, the replicative activity of even hepatocytes can apparently
decrease in chronic hepatic injury in mice and advance cirrhosis in humans, possibly due to
telomere shortening [101]. Regeneration through replication of hepatocytes and cholangio‐
cytes is also known as the “first tier of defense” or a “level 1 response” [4]. This form of response
was responsible was regenerating Prometheus’ liver during night as the eagle essentially
conducted partial hepatectomy during the day.
7. Localizing the hepatic progenitor cell niche
Locating stem cells is the first step into characterizing their niche. Stem cells and their niches
have been defined in several tissues, including the hair follicle and skin, the hematopoietic
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system and in the intestinal crypts [42,44,49,102–105]. These organs are, unlike the liver,
generally under constant renewal and require frequent stem cell division for tissue replenish‐
ment. Stem cells in these organs are therefore fulltime committed to perform stem cell function.
However, stem cells in tissues with low turnover have been notoriously difficult to detect. As
with arrangements in other stem cell niches the hepatic progenitor cell niche is thought to be
structurally composed of a stem or progenitor cell population situated on a basal lamina and
in contact with surrounding support cells [36,38]. As cellular turnover in the liver is already
low and hepatic homeostasis and regeneration to a large extent is completed by differentiated
parenchymal and non-parenchymal cells stem cells in this organ have been difficult to
characterize.
While hepatocytes can conceptually be considered as the livers functional stem cells, the
contribution of hepatic stem or progenitor cells to liver regeneration has been debated. Clues
to a possible existence of stem cells in the liver came from early studies conducted by Farber,
Wilson and Leduc [106,107]. Following dietary administration of DL-ethionine or carcinogenic
2-acetylaminofluorene (2-AAF) to rats, Farber observed the presence of pseudoductular
structures consisting of small cells near the hepatic portal areas in rat liver (figure 2). These
small cells are termed “oval cells” due to their oval shaped nucleus and scant cytoplasm [106].
In a following study Wilson and Leduc examined murine livers following dietary adminis‐
tration of ethionine and bentonite [107]. The presence of small cholangioles apparently giving
rise to both bile-duct cells and parenchymal cells suggested the presence or a population of
reserve cells or stem cells [107]. In acute liver failure and chronic liver diseases similar so-called
“ductular reactions” may be noted at the portal triad interface [7,108–110]. The ductular
response is thought to result from proliferating progenitor cells and represent the livers
“second tier of defense” or “level 2 response” [4]. These cells termed oval cells in rodents are
named progenitor cells in humans as rodent hepatic injury models and human diseases may
not be directly comparable. However, we will collectively refer to them as hepatic progenitor
cells (HPCs). The resulting arborizing network of ductular structures sprouting from the portal
area is classified as an atypical ductular reaction due to a poorly defined lumen.
A number of rodent hepatic injury models have been developed to investigate various modes
of regeneration and to mimic human hepatic diseases. Particularly notable models include
partial hepatectomy, which induces proliferation of differentiated hepatocytes and cholan‐
giocytes and thereby represent the first tier of defense [18,111]. Ligation of the common bile
duct (Bile Duct Ligation) obstructs bile flow from the liver (figure 2). This surgical technique
mimics cholestasis and induces proliferation of hepatocytes and the larger bile ducts without
signs of differentiation towards the hepatocytic lineage in the latter [112,113]. Several injury
models specifically induce HPC responses and thereby the second tier of defense. For example
administration of the choline-deficient ethionine-supplemented (CDE) diet or carcinogenic
agents such as 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) to rodents induces ductular
reactions while carbon tetrachloride (CCl4) administration additionally result in advanced
hepatic fibrosis [114–116]. In the 2-AAF/PHx model administration of 2-acetylaminofluorene
to rats is followed by two-thirds partial hepatectomy. This procedure block hepatocyte
differentiation, ergo the first tier of defense, while at the same time providing a strong stimulus
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for growth. As a result, a ductular response is mounted (figure 2). Although these proliferating
epithelial cells are collectively referred to as oval cells, it remains unclear if the oval cells
resulting from different hepatic insults across different species have common characteristics
as mice and rat respond differently to the same insults [117].
The ductular response is thought to represent proliferating progenitor cells. However, the
origin of these progenitor cells is debated. Ductular reactions initiated, for example in the
2-AAF/PHx  protocol,  display  both  biliary  and  hepatocytic  markers  [26,118,119].  More‐
over,  destruction  of  the  biliary  tree  through  administration  of  4,4’-methylenedianiline
(MDA) inhibits progenitor cell proliferation, suggesting that progenitor cells originate from
the biliary lineage [120]. However, administration of dexamethasone diminishes progeni‐
Figure 2. A. Cartoon of typical constituents of the extracellular matrix. B, C, D. Microphotographic images and car‐
toons of livers from rats subjected to B) sham operation, C) bile duct ligation and D) the 2-AAF-PHx model. Cholangio‐
cytes and progenitor cells are stained for HAI-1 (green) and DLK1 (red). Cartoons in B, C and D portray part of portal
areas with bile ducts (green) and their extracellular matrix in the portal mesenchyme bordering the limiting plate. B) In
sham operated rat liver cholangiocytes are marked by HAI-1. C) In the bile duct ligation model in rats the larger bile
ducts proliferate. D) In the 2-AAF-PHx model in rat liver a ductular reaction contain a subpopulation of hepatic pro‐
genitor cells positive for DLK1. Regardless of injury model extracellular matrix components escort the cholangiocytes.
Upon exiting the hepatic progenitor cell niche the progenitor cells differentiate into hepatocytes. Microphotograph
magnification x100. Adapted from Vestentoft et al. 2013 [129].
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tor cell induction, but has no consequence on proliferation of larger bile ducts [113]. The
anatomical location of the Canal of Hering, at the portal triad interface, makes this structure
a prime candidate for the adult HPC compartment or “niche” [56,120–122]. Based on these
experiments,  the Canal  of  Hering represents,  therefore,  the HPC niche and the ductular
reaction represents the activated HPC niche, respectively. However, the assumed stem cells
located in the Canal of Hering may in fact not be “true” stem cells, but rather subpopula‐
tions of biliary or hepatocytic cells with increased stemness compared to other cells of their
respective  lineage  [3].  Although  progenitor  cells  morphologically  resemble  biliary  cells,
ductular reactions are phenotypically heterogenous [123]. In the ductular end connected to
the biliary tree, the cells display cholangiocytic markers such as CK19, whereas the ductular
end  facing  the  parenchyma  display  hepatocytic  markers  including  HepPar1  and  the
transcription factor HNF4 [119,123].  Between these extremes,  hepatobiliary cells  express‐
ing cholangiocytic  and hepatocytic  markers  to  various degrees are found [123,124].  It  is
now clear that the ductular response can be divided into several distinct phases that are
evident in the 2-AAF/PHx protocol [117]. In the activation phase, on day 1, few proliferat‐
ing HPCs expressing CK19 are  detectable  in  the  biliary ductules.  In  the  early  prolifera‐
tion and migration phase on day 5 multiple CK19-positive HPCs can be observed whereas
progenitor cell expression of delta-like 1 homolog (DLK1/Pref1) and AFP is rare. In the late
proliferation and migration phase on day 9, arborizing ductular structures expand from the
portal area with HPCs expressing CK19, Dlk1 and AFP proteins.
Even though a number of HPC markers have been reported, none are specific for a pure
population of hepatic stem cells [24,123,125,126]. What is more, only few of the reported
HPC markers are expressed on the cellular surface and are therefore able to be employed
for cellular isolation studies. CK19, OV-6 (an antibody recognizing a shared epitope between
CK14 and CK19), EpCAM, CD24, hepatocyte growth factor activator inhibitor type 1 (HAI-1)
and suppressor of tumorigenicity 14 (ST14) decorate both the intrahepatic bile ducts and
the ductular reactions but only EpCAM, CD24, HAI-1 and ST14 are expressed on the surface
[126–129]. AFP and DLK1, however, mark a subpopulation of HPCs suggesting the presence
of an established hierarchy amongst the HPCs [129–131]. AFP and DLK1 are normally not
expressed in the liver. However, both proteins are observed in hepatoblasts, the embryon‐
ic  precursors  to  the  cholangiocytic  and  hepatocytic  lineages,  suggesting  that  oval  cells
recapitulate  a  fetal  phenotype  when  activated  in  hepatic  injuries  [72,132].  DLK1  is  a
transmembrane  protein  often  described  as  an  inhibitor  of  cellular  differentiation  and is
expressed  in  less  differentiated  cells  [133,134].  For  example,  forced  expression  of  Dlk1
inhibits  adipogenesis,  whereas  suppression  promotes  this  process  [133].  It  is  therefore
conceivable that Dlk1 inhibits HPC differentiation thereby allowing transit amplifying cells
to  increase in  numbers  similar  to  the one observed in other  stem cell  niches  [36].  With
regard  to  AFP,  elevated  serum  levels  of  this  protein  are  associated  with  a  favorable
prognosis for patients with fulminant hepatic failure [135,136]. This observation supports
the  assumption  that  AFP  marks  cells  capable  of,  at  least,  differentiating  towards  the
hepatocytic lineage.
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8. Support cells and the hepatic progenitor cell response
Proliferation and morphogenesis of cholangiocytes and HPCs is a complex interplay between
the biliary cells, surrounding support cells and the extracellular matrix. All of these compo‐
nents contribute to the HPC niche. Cell-cell interactions and cell-matrix interplays are likely
to be important for regulating stem cell behavior within niches [37].
Hepatic stellate cells possibly originate from the septum transversum-derived mesothelium
lining the liver [137]. They are recognizable in their quiescent state by the expression of desmin
and glial fibrillary acidic protein (GFAP), whereas they express alpha smooth muscle actin (α-
SMA) when activated, often as a result of hepatic injury [138–141]. In the quiescent state they
reside in the space of Disse, which constitute a laminin coated hepatic stellate cell niche, but
when activated they give rise to contractile myofibroblast [59]. Both cell types are major
producers of extracellular matrix components and activated hepatic stellate cells are the main
source of matrix metalloproteinases and their inhibitors. However, so-called portal fibroblasts
and vascular myofibroblasts can also transform into myofibroblasts thus giving rise to much
confusion about the origins of the latter [142,143]. Additional confusion has been caused by
misinterpretation of cellular markers. In particular, Thy-1, a cell surface protein initially
suggested to mark oval cells, was later reclassified as a marker for hepatic myofibroblasts [144]
Hepatic stellate cells and myofibroblasts are greatly involved in the HPC response. In both the
CDE model of HPC induction in mice, and the 2-AAF/PHx model in rat, hepatic stellate cell
and myofibroblast response are invoked [121,145,146]. Hepatic stellate cells and myofibro‐
blasts not only intimately escort the HPC invasion into the parenchyma, but cellular processes
from the hepatic stellate cells disrupt the HPC basal lamina and form direct cellular contact
[121]. Such direct cell-cell interactions between hepatic stellate cells and liver epithelial cells
has been shown to induce differentiation of the latter into a hepatocytic fate in vitro [147]. The
HPC response is a regulated process undergoing several stages. Both initiation and termination
is under tight regulation and hepatic stellate cells may be involved in these processes. HGF is
a potent mitogen for hepatocytes whereas TGF-β is a strong inhibitor of their proliferation
[148]. TGF-β is additionally identified as a partaker in maintaining quiescence of stem cells in
other niches, such as the melanocyte stem cells located to the hair follicle bulge region [149].
Not only are hepatic stellate cells activated and induced to transform into myofibroblasts by
TGF-β, but hepatic stellate cells themselves are major producers of this cytokine [148].
Conditioned media harvested from hepatic stellate cells in the early HPC response is rich in
hepatocyte growth factor (HGF). This media promote HPC proliferation, possibly due to an
override of the antiproliferative effect of TGF-β [150]. In the terminal phases of liver regener‐
ation hepatic stellate cells change cytokine expression profile and produce high levels of TGF-
β which inhibits proliferation of hepatocytes [150]. Thus, hepatic stellate cells may be involved
in both initiation and termination of the HPC response.
Other cells types involved in the HPC response are macrophages and Kupffer cells. Macro‐
phages can remodel the extracellular matrix, partly through the production of matrix metal‐
loproteinases [151]. As for hepatic stellate cells and myofibroblasts also bone marrow derived
macrophages intimately associate with ductular reactions in rats [145]. Kupffer cells, on the
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other hand, are resident hepatic macrophages. Kupffer cells are greatly activated in the CDE
model of HPC response in mice. Before onset of HPC proliferation and parenchymal invasion
activated Kupffer cells gradually shift from a more periportal location towards a more
centrilobular location. Depletion of Kupffer cells through clodronate injections result in greatly
reduced invasion of HPCs into the hepatic parenchyma. However, HPC proliferation is
unaltered. In conclusion these data suggest that hepatic stellate cells are involved in the
initiation, proliferation and termination of the HPC response, whereas Kupffer cells are needed
for HPC invasion into the hepatic parenchyma.
9. Extracellular matrix components and the hepatic progenitor cell response
Extracellular matrix can be defined as the complex molecular material surrounding cells and
encompass both the basement membrane and the interstitial matrix [152]. Major components
include the respective protein families of collagens, laminins, elastins, proteoglycans and
glycosaminoglycans (figure 2) [152–155].
The extracellular matrix is a dynamic scaffold known to affect aspects of stem cell behav‐
ior such as morphology, growth and survival. A proportion of these responses are due to
interactions between the extracellular matrix components and integrins, a family of dimeric
extracellular matrix receptors that  are linked to and transmit signals to the cytoskeleton
[156,157]. The extracellular matrix may also contain growth factors which provide growth
and morphogenic  signals  to  nearby  cells.  Even physical  features  of  the  matrix,  such  as
rigidity and geometry may influence cellular phenotype and behavior and has been shown
to direct stem cell  lineage specification [152,158–160].  Studies of Drosophila spp.  stem cell
niches have clarified that the microenvironment, as expected, may promote adherence to
the niche and repress stem cell differentiation [36]. What is more, with age the molecular
composition of  the extracellular  matrix  change in an unfavorable  direction for  stem cell
function  and  proliferation.  This  has  been  illustrated  in  experiments  where  stem  cells
transplanted from older mice, where stem cell self-renewal and differentiation has deterio‐
rated,  to  extracellular  matrix  from younger  mice  rejuvenate  stem cell  function  to  levels
comparable to that observed in younger mice [161,162].
Upon induction of the HPC response, the molecular composition of the HPC niche is thought
to change in favor of promoting progenitor cell proliferation. Therefore, a key to understanding
HPC biology and to characterize the HPC niche lies within unravelling the extracellular matrix
composition of the niche. It is of particular interest to clarify which extracellular matrix
molecules regulate the hepatic progenitor cell responses. A number of extracellular matrix
molecules taking part in development of the intrahepatic bile ducts or in modulating the HPC
response have been identified. Particularly, laminin and collagen I and IV are associated with
these processes, but also other extracellular matrix components including tenascin, nidogen 1,
agrin and fibronectin contribute.
The family of collagen fibrils comprises 28 members, all with at least one triple helical domain
and arranged in a rope-like fashion [163,164]. Collagens are deposited in the extracellular space
Adult Hepatic Progenitor Cells
http://dx.doi.org/10.5772/58814
185
and particularly collagen I and collagen IV are implicated in hepatic development and
regeneration [165]. However, their roles seem quite different. Collagen I is the main component
of hepatic fibrosis, where it is laid down by the non-parenchymal hepatic stellate cells and
myofibroblasts and contribute to the formation of scaring tissue [165,166]. Collagen IV, on the
other hand, is part of the basement membrane of adult biliary cells and contributes to the ductal
plate, the prenatal hepatic progenitor cell niche [167,168]. Collagen I and IV delineate expand‐
ing biliary cells not only in the HPC response, but also in the bile duct ligation model [129,146].
Members of the laminin family are trimeric proteins that, as for collagen IV, are part of the
basal  lamina  [169].  In  the  HPC response  laminin  expression  can  be  detected  in  hepatic
stellate cells, myofibroblasts, endothelial cells and the progenitor cells themselves [170–172].
As for collagen IV, laminin contribute to the ductal plate during development and form
the basal lamina escorting the HPC response in close apposition to stellate cells [121,168].
Several studies have highlighted the importance of remodeling the extracellular matrix in
connection with the HPC response. In the CDE-induced murine model of HPC activation
α-SMA positive cells  and an extracellular  matrix  rich in  collagen I  are  deposited in the
periportal  area  prior  to  oval  cell  proliferation [146].  The ECM is  laid  down in  a  porto-
veinous  direction,  thereby  preforming  a  niche  for  the  HPCs  to  invade.  However,  this
invasion  process  is  tightly  correlated  with  ECM remodeling.  Hepatic  macrophages  and
stellate cells  are sources of a variety of extracellular matrix degrading enzymes,  such as
matrix metalloproteinases (MMP) 2,  9,  12 and 13,  and their  inhibitor,  tissue inhibitor  of
metalloproteinase type 1 (TIMP-1) [151,173,174].  Where the CCl4  or CDE-models of HPC
activation  initiate  a  florid  HPC  response  in  wild-type  mice  this  response  is  markedly
attenuated in mice expressing a degradation resistant form of collagen I [175]. These mice
also display a distinct paucity of laminin deposition suggesting that degradation of collagen
is a prerequisite for HPC proliferation and parenchymal invasion.
Where ECM remodeling and collagen I degradation is necessary for the HPC response only
laminin is important for the biliary phenotype. Primary murine HPCs cultured on laminin up-
regulate expression of HPC and biliary associated genes, such as DLK1 and aquaporin 1,
respectively, while hepatocytic gene expression, exemplified by C/EBPα is inhibited [145].
Collagen I and IV, on the other hand, inhibit or do not influence these biliary genes, whereas
fibronectin promote C/EBPα expression. In support of these results, culturing HPCs with
laminin support proliferation and expansion in vitro whereas culturing HPCs with collagen I
result in growth arrest and differentiation [176,177]. The importance of the laminin-rich
activated progenitor cell niche for maintaining the biliary/progenitor phenotype in vivo is also
evident in the HPC response, as disappearance of the basement membrane induces differen‐
tiation [129,178]. Assuming that the canal of Hering truly constitutes the hepatic progenitor
cell niche, this niche therefore appear to be sharply limited by the deposition of collagen I,
collagen IV, laminin, nidogen 1 and agrin [129]. The niche support maintaining the biliary
phenotype and proliferation of HPCs that will differentiate to a hepatocytic phenotype upon
exit from the HPC niche, not unlike the scenario of other stem cell niches [36].
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Stem cell niche component Comment
Progenitor cell niche position The Canal of Hering Most distal part of the bile duct system. Composed
of cholangiocytes and hepatocytes. Link bile ducts
with canaliculi between hepatocytes.
Progenitor cell origin Possibly the biliary lineage Administration of dexamethasone selective
diminishes the progenitor cell response.
Progenitor cell composition Phenotypically heterogenous Progenitor cells display biliary (CK19) and
hepatocytic markers (HepPar1, HNF4α) to various
degrees.
Progenitor cell markers AFP, NCAM, DLK1/Pref1 NCAM and DLK1/Pref1 are cell surface markers. AFP
and DLK1/Pref1 are expressed during hepatic
development.
Associated cell types Kupffer cells Necessary for invasion of ductular reactions into the
hepatic parenchyma.
Hepatic stellate cells Intimately associate with ductular reactions. Are
necessary for initiation, proliferation and
termination of ductular reactions.




Collagen I + IV
Nidogen 1
Agrin
Laminin is essential for maintaining the biliary
phenotype.
Table 1. Summary of components associated with the activated hepatic progenitor cell niche.
10. Activation and aberrant hepatic stem cell activation.
Animal studies have clarified that when regeneration through hepatocytic division fail HPCs
from the canal of Hering contribute to liver regeneration. Despite several protein markers, such
as Dlk1, EpCAM, CK19 and AFP, are associated with HPCs a pure population of hepatic stem
cells or their niche have not been defined [83,179–182]. However, as elevated levels of AFP are
associated with increased survival of patients suffering from acetaminophen-induced liver
injury, hepatic stem cells may be activated in acute hepatic diseases [136]. OV6 and CK7 mark
ductular reactions and intermediate hepatocytes, i.e. progenitor cells on route to a hepatocytic
fate, suggesting stem cell involvement in a variety of human diseases and syndromes. These
include hepatitis C virus infection, fatty liver disease and acute processes such as submassive
liver cell necrosis, [183]. Generally, HPC activation seems correlated with the severity of
inflammation and fibrosis [184]. In addition, the more aggressive the hepatocellular injury is,
the larger a proportion of intermediate hepatocytes are observed [184]. Interestingly, the
protein deleted in malignant brain tumor 1 (dbmt1) is specifically associated with ductular cell
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populations emerging after acetaminophen intoxication or infection with hepatitis B virus but
not in primary biliary cirrhosis or large bile duct obstruction. Dbmt1 therefore may have a role
in cellular fate decision [185].
Liver cancer is the second most frequent cause of cancer death in men and the sixth leading
cause of cancer death in women [186]. Hepatocellular carcinoma (HCC) represent the major
histological subtype accounting for 70-85 % of primary livers cancers, followed by an increase
in incidents of intrahepatic cholangiocarcinomas (ICC) [186,187]. Given that cancer cells and
stem cells share certain characteristics cancer is proposed to represent an abnormal stem cell
disease [188,189]. Both categories of cells can self-renew, divide unlimited and give rise to
heterogeneous progeny. Indeed, certain gliomas, intestinal adenomas and squamous skin
tumours are now attributed to cancer stem cells (CSCs) [190–193]. Liver cancer most frequently
arise in chronic liver diseases, such as chronic hepatitis, cirrhosis or both, where hepatocytic
regeneration and continuous inflammation occur [194,195]. Hepatocarcinogenesis is consid‐
ered as a slow process in which genomic changes progressively alter the hepatocellular
phenotype [194]. In chronic liver diseases, the hepatic microenvironment is substantially
altered in a fashion promoting cellular damage. Stellate cells are activated and infiltrating
lymphocytes may cause inflammation through the release of free radicals and cytokines,
resulting in DNA damage and cell proliferation, factors that may promote aberrant HPC
activation [196,197]. However, as the hepatic stem cells are not fully defined, their involve‐
ments in these liver cancers have not been conclusively established. In addition to accumula‐
tion of genomic and epigenetic changes of genes and regulatory pathways the hepatic
microenvironment is also involved in promoting liver cancer. For instance, activated hepatic
stellate cells locate in the space between endothelial cells and trabeculae of cancer cells in HCC
patients [198]. Conditioned media from such activated hepatic stellate cells both increase
proliferation and migration of human HCC cells [199]. Thus, activated hepatic stellate cells
may both drive fibrosis and proliferation of HCC cells.
A third form of primary liver cancer is the rare HCC-cholangiocarcinoma (HCC-CCA). In
addition to the heterogenous cellular morphology also displayed by HCCs and ICCs, HCC-
CCA’s show signs of both hepatocellular and biliary epithelial differentiation [200]. Indeed,
analysis of the expression pattern of hepatocytic marker HepPar1 and cholangiocytic markers
CK7, CK19, EpCAM and CD133 in HCC-CCA’s reveal subpopulations of cancer cells coex‐
pressing both categories of markers [182,200–203]. These results seemingly confirm the
hypothesis that HCC-CCA are of HPC origin and human hepatocarcinogenesis may originate
from the transformation of HPCs [200]. The identification of bipotent CSCs possibly originat‐
ing from HPCs is interesting, as stem cell like expression patterns in liver cancers reflect a
particularly malignant nature and poor prognostic outcome [182,204–206]. However, the
identification of bipotent cancer stem cells also opens for new therapeutic applications.
Identification and elimination of CSCs could provide more effective treatment of certain
tumors and prevent reoccurrence. Unfortunately, the niche controlling self-renewal, prolifer‐
ation and differentiation of HPCs and CSCs is still not well described and the putative hepatic
stem cells remain unidentified.
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11. Conclusion and perspectives
The present chapter has attempted to provide a simplified overview of current knowledge of
hepatic stem cells and their niches. Unfortunately, the putative hepatic stem cell has not been
identified and therefore not been characterized. Knowledge of the hepatic stem cell therefore
mainly originates from analysis of its progeny, the hepatic progenitor cells, in animal models
where regeneration through hepatocyte division is impaired. As a result, the location of the
HPC niche is unknown. However, evidences point to the canal of Hering as the HPC niche.
Assuming that the canal of Hering truly represent the hepatic stem cell niche, and that HPCs
are descendants of hepatic stem cell, animal studies and their corresponding human diseases
has provided us with some knowledge of the constituents in the activated HPC niche:
• Activated hepatic progenitor cells are phenotypically heterogeneous and to various degrees
display markers of the biliary and hepatocytic lineages.
• A cellular hierarchy is present with AFP, DLK1 and NCAM marking subpopulations of
HPCs [123].
• Hepatic stellate cells and macrophages intimately associate with the ductular reactions.
• Hepatic stellate cells are necessary for initiation, proliferation and termination of ductular
reactions.
• Kupffer cells are necessary for invasion of ductular reactions into the hepatic parenchyma.
• The extracellular matrix in the HPC micromillieu contain laminin, collagen I and IV, nidogen
1 and agrin.
• Laminin is necessary for maintaining the biliary phenotype of the HPCs.
• HPCs differentiate into hepatocytes upon exit from the activated HPC niche.
The establishment of HPC subpopulations suggests the presence of progenitor cells at different
stages of differentiation. Identifying additional proteins expressed on the HPC surface could
facilitate isolation and characterization of these subpopulations and evaluation of their
potential for differentiation. Furthermore, as hepatic stem cells may be implicated in devel‐
opment of primary liver cancers, better characterization of the hepatic progenitor cells could
provide new targets for treatment of cancerous diseases. Aberrant progenitor cell activation
and proliferation is also dependent on the hepatic microenvironment. As stellate cells and
Kupffer cells are involved in the proliferation and invasion of HPCs these cell types could also
provide targets for alleviating HPC derived cancers. In addition, targeting stellate cells has the
potential to reduce hepatic fibrosis. Therefore, more research is needed into characterizing the
hepatic progenitor cell niche and obtaining a better understanding of the activation and
differentiation of the hepatic progenitor cells.






ASMA: alpha smooth muscle actin.
BMP: Bone morphogenetic protein.
BrdU: 5-Bromo-2´-Deoxyuridine.
CCl4: Carbon tetrachloride.
CDE: Choline-deficient, ethionine supplemented.
CK: Cytokeratin.
CSC: Cancer Stem Cell.
DDC: 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
DLK1: Delta-Like 1 Homolog.
Dmbt1: Deleted in malignant brain tumors 1
FGF: Fibroblast growth factor.
GFAP: Glial fibrillary acidic protein.
HAI-1: Hepatocyte Growth Factor Activator Inhibitor Type 1.
HCC: Hepatocellular carcinoma.
HCC-CCA: HCC-cholangiocarcinoma.
HepPar1: Hepatocyte Paraffin 1.
HGF: Hepatocyte growth factor.
HNF: Hepatocyte nuclear factor.




NCAM: Neural Cell Adhesion Molecule.
OV6: Oval Cell Marker Antibody 6.
PHx: Partial hepatectomy.
ST14: Suppressor of tumorigenicity 1.
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SOX9: SRY-related HMG box transcription factor 9.
TIMP-1: tissue inhibitor of metalloproteinase 1.
Vegfr2: Vascular endothelial growth factor receptor-2.
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